There are many different types of pancreas cancer, but two of the most common are adenocarcinomas and acinar neoplasms. In fact, these two terms are used interchangeably. While ductal adenocarcinoma (PDAC) is the most common type of pancreatic cancer, the term pancreatic cancer encompasses a wide variety of malignant neoplasms.
The standard treatment for localized pancreatic cancer involves surgery to remove the tumor and chemotherapy or radiation. However, over 80 percent of patients develop tumors outside of the pancreas, preventing them from receiving surgery. Additionally, patients who do undergo surgery still face 50-90% local recurrence. So, it is vital to seek treatment early. However, the benefits of early diagnosis far outweigh the risks.
Symptoms vary between the different types of pancreas cancer. Early signs of pancreas cancer may include vague abdominal complaints, bloating, gassiness, or stool changes. In about 40 percent of cases, jaundice will occur. Jaundice is a classic early sign of pancreatic cancer. The most common pancreatic cancer symptoms are described below. For more information about pancreas cancer, contact a physician today.
Pancreatic cancer is the 11th most common cancer among U.S. adults and is the third leading cause of cancer death. In 2016, it passed breast cancer as the third leading cause of cancer-related deaths. The disease is highly aggressive and is notoriously difficult to treat, so early detection is critical. Only 15-20% of patients with pancreas cancer are candidates for curative therapy. There is currently no cure for pancreatic cancer, but many treatments can help.
Pancreatic cancer has a slightly increased risk for African-Americans and whites. Compared to other types of cancer, smoking increases the risk for pancreas cancer by three times. But it’s important to note that smoking is a risk factor for at least twenty percent of pancreatic cancer cases. Other factors that increase the risk of pancreas cancer include obesity, long-standing diabetes, and family history.
Although it’s not yet proven that chemotherapy can cure pancreas cancer, neoadjuvant chemotherapy is an increasingly common option for treatment. Studies show that chemotherapy regimens with FU are effective for a variety of cancers, and can improve patient outcomes. While neoadjuvant chemotherapy is not as effective as surgery, it does reduce the likelihood of local relapse. It also reduces the risk of amputation of a pancreas cancer.
After a patient’s diagnosis of pancreatic cancer, the physician will usually perform an endoscopic ultrasound. At home, patients will often research their condition on the internet, and will go to their medicul with an understanding of the disease. However, these individuals will also be racked with fear and anxiety. The fear and anxiety that come with this diagnosis can cause patients to miss important treatments. They should discuss their options with their doctor and make sure that the disease is treated accordingly.
The hope is that new treatments for pancreatic cancer are in the works. While many research studies have not yet been able to prove this theory, Dr. Lowy has led numerous studies and is credited with the creation of the genetically engineered mouse. His mother died of pancreatic cancer when she was 35 years old, and the research may one day help to improve patient outcomes. And, as a scientist, Dr. Lowy has personal experience with pancreatic cancer. After losing her sister to the disease in 2016, she became a spokesperson for research to help prevent pancreatic cancer.
